{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:10:36Z","timestamp":1793502636048,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070588"],"award-info":[{"award-number":["82070588"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000690"],"award-info":[{"award-number":["82000690"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Public Health in Zhejiang Province","award":["S2032102600032"],"award-info":[{"award-number":["S2032102600032"]}]},{"name":"Department of Public Health in Zhejiang Province","award":["QNRC075"],"award-info":[{"award-number":["QNRC075"]}]},{"name":"Wuxi Municipal Health Commission","award":["Q201932"],"award-info":[{"award-number":["Q201932"]}]},{"name":"Young and Middle-Age Health Care in Wuxi"},{"name":"University School of Medicine of Verona"},{"name":"NIHR Biomedical Research Centre","award":["IS-BRC-20004"],"award-info":[{"award-number":["IS-BRC-20004"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.metabol.2020.154433","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T11:17:15Z","timestamp":1605525435000},"page":"154433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":294,"special_numbering":"C","title":["MAFLD and risk of CKD"],"prefix":"10.1016","volume":"115","author":[{"given":"Dan-Qin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth I.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael S.","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2020.154433_bb0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000497540","article-title":"For the world kidney day steering C. burden, access, and disparities in kidney disease","volume":"49","author":"Crews","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.metabol.2020.154433_bb0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","article-title":"Global liver disease burdens and research trends: analysis from a Chinese perspective","volume":"71","author":"Xiao","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2020.154433_bb0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrneph.2017.16","article-title":"Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease","volume":"13","author":"Targher","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.metabol.2020.154433_bb0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.diabet.2019.11.003","article-title":"Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD","volume":"46","author":"Sun","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.metabol.2020.154433_bb0025","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2020.154433_bb0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","article-title":"Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis","volume":"79","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2020.154433_bb0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2020.154433_bb0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2020.154433_bb0045","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology."},{"key":"10.1016\/j.metabol.2020.154433_bb0050","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: when pathophysiology succeeds","volume":"17","author":"Tilg","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2020.154433_bb0055","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/liv.14478","article-title":"What\u2019s in a name? Renaming \u2018NAFLD\u2019 to \u2018MAFLD\u2019","volume":"40","author":"Fouad","year":"2020","journal-title":"Liver international"},{"key":"10.1016\/j.metabol.2020.154433_bb0060","doi-asserted-by":"crossref","first-page":"154244","DOI":"10.1016\/j.metabol.2020.154244","article-title":"Letter to the editor: obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease","volume":"108","author":"Zheng","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2020.154433_bb0065","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver international"},{"key":"10.1016\/j.metabol.2020.154433_bb0070","doi-asserted-by":"crossref","DOI":"10.21037\/hbsn-20-725","article-title":"When a new definition overhauls perceptions of MAFLD related cirrhosis care","author":"Zheng","year":"2020","journal-title":"Hepatobiliary surgery and nutrition"},{"key":"10.1016\/j.metabol.2020.154433_bb0075","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2020.154433_bb0080","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.31040","article-title":"Attributable fractions of NAFLD for mortality in the United States: results from NHANES III with 27 years of follow-up","volume":"72","author":"Alvarez","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2020.154433_bb0085","author":"National Center for Health Statistics"},{"key":"10.1016\/j.metabol.2020.154433_bb0090","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","article-title":"Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease","volume":"49","author":"Ong","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2020.154433_bb0095","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2020.154433_bb0100","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2020.154433_bb0105","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/MEG.0000000000001169","article-title":"Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis","volume":"30","author":"Wijarnpreecha","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2020.154433_bb0110","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/CM9.0000000000000981","article-title":"From NAFLD to MAFLD: a \u201credefining\u201d moment for fatty liver disease","volume":"133","author":"Zheng","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.metabol.2020.154433_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.metabol.2020.154433_bb0120","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","article-title":"CKD and nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2014","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.metabol.2020.154433_bb0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jfma.2019.02.010","article-title":"The correlation between fatty liver disease and chronic kidney disease","volume":"119","author":"Chen","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.metabol.2020.154433_bb0130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/joim.12964","article-title":"Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study","volume":"286","author":"Park","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2020.154433_bb0135","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/ndt\/gfy032","article-title":"Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies","volume":"33","author":"Minutolo","year":"2018","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.metabol.2020.154433_bb0140","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/ndt\/gfr644","article-title":"High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study","volume":"27","author":"Sasso","year":"2012","journal-title":"Nephrology, dialysis, transplantation"},{"key":"10.1016\/j.metabol.2020.154433_bb0145","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/01.hjh.0000239303.93872.31","article-title":"Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings","volume":"24","author":"Minutolo","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2020.154433_bb0150","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520302973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520302973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:25:03Z","timestamp":1758428703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049520302973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":30,"alternative-id":["S0026049520302973"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154433","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MAFLD and risk of CKD","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154433"}}